IP Library Granted Patent US 12,378,539
Granted Patent B2
US 12,378,539 · App. 18/915,656 · Granted Aug 5, 2025

Evolved integrases and methods of using the same for genome editing

Inventors: Jesse B. Owens (Honolulu, HI); Brian Hew (Honolulu, HI)
Assignee: University of Hawaii
C12N9/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,378,539
App. No.
18/915,656
Granted
Aug 5, 2025
Kind
B2
Abstract

Disclosed are evolved Bxb1 and PhiC31 integrases that exhibit increased insertion activity and efficiency as compared to their wild-type counterparts and use of the evolved integrases to modify any sequence within the genome of a cell or subject.

Claims (108)

1. A Bxb1 integrase comprising:

an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 1; and

one or more amino acid mutations at positions selected from L4I, E42K, R57K, R63K, V76I, H111P, V122M, and V187I, relative to SEQ ID NO: 1.

2. The Bxb1 integrase of claim 1 , comprising an amino acid sequence that is at least 99% identical to the amino acid sequence of SEQ ID NO: 1.

3. The Bxb1 integrase of claim 1 , further comprising one or more amino acid mutations selected from D36N, V40A, A49S, V74I, I87L or I87A or I87S, H89G, V175A, V179A, R287H, A288V, T453I, and H496N.

4. The Bxb1 integrase of claim 1 , further comprising one or more amino acid mutations selected from V40I, D45G, I75V, H95Y, A119S, A280T, A311V, E434G, and V466M.

5. The Bxb1 integrase of claim 1 , wherein one or more of the following amino acids relative to SEQ ID NO: 1 are not mutated: A62, H100, G209, P295, L302, C307, L387, E419, S428, E483, and R487.

6. The Bxb1 integrase of claim 1 , comprising the mutation V122M.

7. The Bxb1 integrase of claim 6 , further comprising the mutation A369P.

8. A Bxb1 integrase comprising an amino acid sequence that is at least 99% identical to the amino acid sequence of SEQ ID NO: 1 and having the amino acid mutations I87L, A369P, and E434G; the amino acid mutations V122M, A369P, and E434G; or the amino acid mutations H95Y, A369P, and E434G.

9. A Bxb1 integrase comprising:

an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 1; and

one or more amino acid mutations selected from R319K, A341D, D359A, A369P, A398S, R416K, A425T, L479I, and M499T, relative to SEQ ID NO: 1.

10. The Bxb1 integrase of claim 9 , comprising an amino acid that is at least 99% identical to the amino acid sequence of SEQ ID NO: 1.

11. The Bxb1 integrase of claim 9 , further comprising one or more amino acid mutations selected from D36N, V40A, A49S, V74I, I87L or I87A or I87S, H89G, V175A, V179A, R287H, A288V, T453I, and H496N.

12. The Bxb1 integrase of claim 9 , further comprising one or more amino acid mutations selected from V40I, D45G, I75V, H95Y, A119S, A280T, A311V, E434G, and V466M.

13. The Bxb1 integrase of claim 9 , wherein one or more of the following amino acids relative to SEQ ID NO: 1 are not mutated: A62, H100, Q191, P195, G209, P295, L302, C307, L387, E419, S428, E483, and R487.

14. The Bxb1 integrase of claim 9 , further comprising the mutation V122M.

15. The Bxb1 integrase of claim 9 , comprising the mutation A369P.

16. A Bxb1 integrase comprising:

an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 1; and

a combination of amino acid mutations selected from:

A119S, A369P, and E434G;

A288V, A311V, A398S, R416K, T453I, H496N, and E42K,

A369P and E434G;

A49S, A369P, and E434G;

A49S, I87L, A369P, and E434G;

A49S, V122M, A369P, and E434G;

D36N, A369P, and E434G;

D36N, I87L, A369P, and E434G;

D36N, V122M, A369P, and E434G;

D45G, A369P, and E434G;

E42K, H95Y, A369P, and E434G;

E42K, V76I, and I87L;

H111P and E434G

H95, V122M and A369P;

H95Y and A341D;

H95Y and A369P;

H95Y and K313R;

H95Y and V122M;

H95Y, A369P, A425T, and E434G;

H95Y, A369P, and E434G;

H95Y, A369P, E434G, and L479I;

H95Y, A369P, E434G, and V466M;

H95Y, R319K, A369P, and E434G;

H95Y, V122M and E434G;

H95Y, V179A, A369P, and E434G;

I75V and V76I;

I87L and A341D;

I87L and A369P;

I87L and A425T;

I 87L and D359A;

I87L and L479I;

I87L and L4I;

I87L and R319K;

I87L and V122M;

I87L, A341D, A369P, and E434G;

I87L, A341D, and R287H;

I87L, A369P, A425T, and E434G;

I87L, A369P, and E434G;

I87L, A369P, E434G, and R319K;

I87L, D359A, A369P, and E434G;

I87L, H95Y, A369P and E434G;

I87L, H95Y, and A369P;

I87L, H95Y, V122M, and E434G;

I87L, R287H, A369P, and E434G;

I87L, R287H, A369P, E434G, and A341D;

I87L, R57K, and R63K;

I87L, V122, A369P, and E434G;

I87L, V122M, and A369P;

I87L, V122M, and E434G;

I87L, V175A, and D359A;

L4I and V76I;

L4I, H95Y, A369P, and E434G;

L4I, I87L, A369P, and E434G;

L4I, V122M, A369P, and E434G;

R57K, I87L, A369P, and E434G;

R57K, R63K and H95Y;

R57K, R63K, I87L, A369P, and E434G;

R57K, R63K, V122M, A369P, and E434G;

R63K and I87L;

R63K and V122M;

R63K, A119S, and M499T;

R63K, I87L, A369P, and E434G;

R63K, I87V, and N194D;

R63K, V122M, A369P, and E434G;

R63K, V122M, R319K, and V40I;

V122M and A369P;

V122M and E434G;

V122M, A369P, A425T, and E434G;

V122M, A369P, and E434G;

V122M, A369P, E434G, and A341D;

V122M, A369P, E434G, and R319K;

V122M, A369P, E434G, and V175A;

V122M, D359A, A369P, and E434G;

V122M, R287H, A341D, A369P, and E434G;

V122M, R287H, A369P, and E434G;

V122M, V175A, D359A, A369P, and E434G;

V40A, R63K, and H89G;

V40I, H95Y, A369P, and E434G;

V74I and V76I;

V74I, I75V, and V76I;

V76I and A119S;

V76I and A369P;

V76I and V122M;

V76I, A369P, and E434G;

V76I, I87L, and K313R; and

V76I, V122M, and A369P.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2024
From: OWENS, JESSE B.; HEW, BRIAN
To: UNIVERSITY OF HAWAI'I
Reel/Frame 069279/0108 →
Continuity (4)
Continuation PCTUS2024035414 · Jun 25, 2024
Provisional Application 63592945 · Oct 25, 2023
Provisional Application 63510171 · Jun 26, 2023
Related Publication 20250043263A1 · Feb 6, 2025
References Cited (124)
US 6187994B1 · Baszczynski et al. · 2001 [cited by applicant]
US 6890726B1 · Sauer et al. · 2005 [cited by applicant]
US 7732585B2 · Calos · 2010 [cited by applicant]
US 8940533B2 · Oshimura et al. · 2015 [cited by applicant]
US 9023594B2 · Liu et al. · 2015 [cited by applicant]
US 9394537B2 · Liu et al. · 2016 [cited by applicant]
US 9691017B2 · Lu et al. · 2017 [cited by applicant]
US 9765352B2 · Gordon-Kamm et al. · 2017 [cited by applicant]
US 9771574B2 · Liu et al. · 2017 [cited by applicant]
US 9816077B2 · Kolot et al. · 2017 [cited by applicant]
US 9932607B2 · Calos et al. · 2018 [cited by applicant]
US 10081817B2 · Padidam · 2018 [cited by applicant]
US 10336997B2 · Liu et al. · 2019 [cited by applicant]
US 10344301B2 · Ghadessy et al. · 2019 [cited by applicant]
US 10392674B2 · Liu et al. · 2019 [cited by applicant]
US 10480009B2 · Lu et al. · 2019 [cited by applicant]
US 10731153B2 · Weiss et al. · 2020 [cited by applicant]
US 11030531B2 · Wong et al. · 2021 [cited by applicant]
US 11104967B2 · Liu et al. · 2021 [cited by applicant]
US 11214792B2 · Liu et al. · 2022 [cited by applicant]
US 11492613B2 · Farruggio et al. · 2022 [cited by applicant]
US 11591604B2 · Lu et al. · 2023 [cited by applicant]
US 11827881B2 · Abudayyeh et al. · 2023 [cited by applicant]
US 11905623B2 · Liu et al. · 2024 [cited by applicant]
US 11912985B2 · Liu et al. · 2024 [cited by applicant]
US 11946054B2 · Shah et al. · 2024 [cited by applicant]
US 11959093B2 · Kong et al. · 2024 [cited by applicant]
US 12129480B2 · Ng et al. · 2024 [cited by applicant]
US 20060046294A1 · Ow et al. · 2006 [cited by applicant]
US 20060172377A1 · Padidam · 2006 [cited by applicant]
US 20080020465A1 · Padidam · 2008 [cited by applicant]
US 20080241116A1 · Calos · 2008 [cited by applicant]
US 20100086532A1 · Barbas, III et al. · 2010 [cited by applicant]
US 20110136237A1 · Ow et al. · 2011 [cited by applicant]
US 20120141441A1 · Calos et al. · 2012 [cited by applicant]
US 20150275232A1 · Padidam · 2015 [cited by applicant]
US 20160145645A1 · Bahr et al. · 2016 [cited by applicant]
US 20190169634A1 · Lu et al. · 2019 [cited by applicant]
US 20200255844A1 · Kosuri et al. · 2020 [cited by applicant]
US 20200370067A1 · Monnat, Jr. et al. · 2020 [cited by applicant]
US 20210002669A1 · Ng et al. · 2021 [cited by applicant]
US 20210123065A1 · Murphy et al. · 2021 [cited by applicant]
US 20210309988A1 · Sealover et al. · 2021 [cited by applicant]
US 20220025406A1 · Bachiller Perez et al. · 2022 [cited by applicant]
US 20220127642A1 · Tsai et al. · 2022 [cited by applicant]
US 20220139496A1 · Kemble et al. · 2022 [cited by applicant]
US 20220195465A1 · Bahr et al. · 2022 [cited by applicant]
US 20220369610A1 · Wiles et al. · 2022 [cited by applicant]
US 20230287441A1 · Abudayyeh et al. · 2023 [cited by applicant]
US 20230340467A1 · Liu et al. · 2023 [cited by applicant]
US 20230383274A1 · Abudayyeh et al. · 2023 [cited by applicant]
US 20240084291A1 · Munding et al. · 2024 [cited by applicant]
US 20240093210A1 · Jõers et al. · 2024 [cited by applicant]
US 20240240156A1 · Shen et al. · 2024 [cited by applicant]
US 20240263153A1 · Rubens et al. · 2024 [cited by applicant]
US 20240263183A1 · Shah et al. · 2024 [cited by applicant]
US 20240271161A1 · Rubio et al. · 2024 [cited by applicant]
CN 116004586A · 2023 [cited by applicant]
EP 4133086A1 · 2023 [cited by applicant]
EP 4380969A1 · 2024 [cited by applicant]
WO WO2021102390 · 2021 [cited by applicant]
WO WO2021226558 · 2021 [cited by applicant]
WO WO2021220020A1 · 2021 [cited by applicant]
WO WO2022251356 · 2022 [cited by applicant]
WO WO2023070031 · 2023 [cited by applicant]
WO WO2023076898A1 · 2023 [cited by applicant]
WO WO2023116929A1 · 2023 [cited by applicant]
WO WO2023147507 · 2023 [cited by applicant]
WO WO2024026378A2 · 2024 [cited by applicant]
WO WO2024138194A1 · 2024 [cited by applicant]
WO WO2024155830A2 · 2024 [cited by applicant]
WO WO2024168147A2 · 2024 [cited by applicant]
WO WO2024170866A1 · 2024 [cited by applicant]
UniProt ID A0A2P1N3E5_9CAUD, https://www.uniprot.org/uniprotkb/A0A2P1N3E5/entry (Year: 2018). [cited by examiner]
Jusniak et al., Comparison of Integrases Identifies Bxb1-GA Mutant as the Most Efficient Site-Specific Integrase System in Mammalian Cells. ACS Synth Biol. Jan. 18, 2019;8(1):16-24. doi: 10.1021/acssynbio.8b00089. Epub … [cited by examiner]
International Search Report & Written Opinion PCT Application No. PCT/US2024/035414, dated Jan. 10, 2025, 19 pages. [cited by applicant]
Birling, et al., “Site-specific recombinases for manipulation of the mouse genome”, Methods Mol Biol. 2009; 561:245-63. [cited by applicant]
Fogg, et al., “New applications for phage integrases”, J Mol Biol. Jul. 2014. 29; 426(15):2703. [cited by applicant]
Gopaul, et al., “Structure and mechanism in site-specific recombination”, Curr Opin Struct Biol. Feb. 1999; 9(1):14-20. [cited by applicant]
Grainge, et al., “The integrase family of recombinase: organization and function of the active site”, Mol Microbiol. Aug. 1999; 33(3):449-56. [cited by applicant]
Grindley, et al., “Mechanisms of site-specific recombination”, Annu Rev Biochem. 2006; 75:567-605. [cited by applicant]
Smith, et al., “Diversity in the serine recombinases”, Mol Microbiol. Apr. 2002; 44(2):299-307. [cited by applicant]
Smith, et al., “Site-specific recombination by phiC31 integrase and other large serine recombinases”, Biochem Soc Trans. Apr. 2010; 38(2):388-94. [cited by applicant]
Albert et al., Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome, (1995) [cited by applicant]
Anzalone, et al., “Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing,” (2022) [cited by applicant]
Badran et al., “Continuous evolution of [cited by applicant]
Balabaskaran-Nina, et al., “Diverse target gene modifications in Plasmodium falciparum using Bxb1 integrase and an intronic attB”, Parasit & Vectors. Oct. 17, 2018;11(1):548. doi: 10.1186/s13071-018-3129-5. [cited by applicant]
Chalberg et al., “Integration Specificity of Phage ΦC31 Integrase in the Human Genome,” (2006) [cited by applicant]
Chen et al., “Enhanced prime editing systems by manipulating cellular determinants of editing outcomes,” (2021) [cited by applicant]
Doman et al., “Designing and executing prime editing experiments in mammalian cells,” (2022) [cited by applicant]
Durrant, et al., “Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome”, Nature Biotechnology. Apr. 2023;41(4):488-499. doi: 10.1038/s41587-022-01494-w. Epub Oct. 1… [cited by applicant]
Erhardt, et al., “Protocol for large DNA transgenesis in mice using the Cas9+Bxb1 toolbox” Cell Press (2024). [cited by applicant]
Esvelt et al., “A System for the Continuous Directed Evolution of Biomolecules,” (2011) [cited by applicant]
Fauser, et al., “Systematic Development of Reprogrammed Modular Integrases Enables Precise Genomic Integration of Large DNA Sequences,” bioRxiv [preprint publication], May 10, 2024, doi: https://doi.org/10.1101/2024.05.… [cited by applicant]
Gaidukov, et al., “A multi-landing pad DNA integration platform for mammalian cell engineering”, Nucleic Acids Res. May 4, 2018;46(8):4072-4086. doi: 10.1093/nar/gky216. [cited by applicant]
Ghanbari, et al., “Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase-mediated cassette exchange hybrid system”, Appl Microbiol Biotechnol. Feb. 2023;107(2-3):769-783. doi: 10.1007/s00253-022-12322-1. E… [cited by applicant]
Ghosh et al., “The Orientation of Mycobacteriophage Bxb1 Integration Is Solely Dependent on the Central Dinucleotide of attP and attB,” (2003) [cited by applicant]
Groth, at al., “A phage integrase directe efficient site-specific integration in human cells,” (2000) [cited by applicant]
Hew, et al., “Directed evolution of hyperactive integrases for site specific insertion of transgenes,” bioRxiv [preprint publication], Jun. 11, 2024, doi: https://doi.org/10.1101/2024.06.10.598370. [cited by applicant]
Hosur, et al., “Programmable RNA-Guided Large DNA Transgenesis by CRISPR/Cas9 and Site-Specific Integrase Bxb1”, Front Bioeng Biotechnol. Jul. 5, 2022;10:910151. doi: 10.3389/fbioe.2022.910151.eCollection 2022. [cited by applicant]
Hou, et al., “An open-source system for in planta gene stacking by Bxb1 and Cre recombinases”, Mol Plant. Dec. 2014;7(12):1756-65. doi: 10.1093/mp/ssu107. Epub Oct. 3, 2014. [cited by applicant]
Huhtinen, et al., “Increased stable integration efficiency in CHO cells through enhanced nuclear localization of Bxb1 serine integrase”, BMC Biotechnology (2024). [cited by applicant]
Inniss, et al., “A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO Cells”, Biotechnol Bioeng. Aug. 2017;114(8):1837-1846. doi: 10.1002/bit.26268. Epub Mar. … [cited by applicant]
Irion et al., “Identification and targeting of the ROSA26 locus in human embryonic stem cells,” (2007) [cited by applicant]
Jost et al., “Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs,” (2020) [cited by applicant]
Jusiak, et al., “Comparison of Integrases Identifies Bxb1-GA Mutant as the Most Efficient Site-Specific Integrase System in Mammalian Cells”, ACS Synth Biol. Jan. 18, 2019;8(1):16-24. doi: 10.1021/acssynbio.8b00089. Epu… [cited by applicant]
Keenholtz, et al., “Crossover-site sequence and DNA torsional stresscontrol strand interchanges by the Bxb1 site-specific serine recombinase”, Nucleic Acids Research, 2016, vol. 44, No. 18, 8921-8932. Aug. 22, 2016. [cited by applicant]
Keravala et al., “Mutational Derivatives of PhiC31 Integrase With Increased Efficiency and Specificity,” (2009) [cited by applicant]
Low, et al., “Efficient targeted transgenesis of large donor DNA into multiple mouse genetic backgrounds using bacteriophage Bxb1 integrase”, Sci Rep. Jul. 20, 2023;13(1):11756. doi: 10.1038/s41598-023-39015-7. [cited by applicant]
Miller et al., “Phase-assisted continuous and non-continuous evolution,” (2020) [cited by applicant]
Nelson et al., “Engineered pegRNAs improve prime editing efficiency,” (2022) [cited by applicant]
Oceguera-Yanez et al., “Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives,” (2016) [cited by applicant]
Pandey, et al., “Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing”, Nature Biomedical Engineering, Jun. 10, 2024. [cited by applicant]
Roelle, et al., “Mammalian Genomic Manipulation with Orthogonal Bxb1 DNA Recombinase Sites for the Functional Characterization of Protein Variants”, ACS Synth Biol. Nov. 17, 2023;12(11):3352-3365. doi: 10.1021/acssynbio… [cited by applicant]
Shao, et al., “Precise excision of plastid DNA by the large serine recombinase Bxb1”, Plant Biotechnol J. Apr. 2014;12(3):322-9. doi: 10.1111/pbi.12139. Epub Nov. 22, 2013. [cited by applicant]
Tomimatsu, et al., “Multiple expression cassette exchange via TP901-1, R4, and Bxb1 integrase systems on a mouse artificial chromosome”, FEBS Press (2017). [cited by applicant]
Voutev, et al., “Bxb1 phage recombinase assists genome engineering in Drosophila melanogaster”, Biotechniques. Jan. 1, 2017;62(1):37-38. doi: 10.2144/000114494. [cited by applicant]
Voziyanov et al. “A dual reporter screening system identified the amino acid at position 82 in Flp site-specific recombinase as a determinat for target specificity,” (2002) [cited by applicant]
Wang, et al., “Bxb1 integrase serves as a highly efficient DNA recombinase in rapid metabolite pathway assembly”, Acta Biochim Biophys Sin (Shanghai). Jan. 2017;49(1):44-50. doi: 10.1093/abbs/gmw115. Epub Nov. 17, 2016. [cited by applicant]
Wang, et al., “Efficient targeted insertion of large DNA fragments without DNA donors,” (2022) [cited by applicant]
Wilkins et al., “Ultraplex: A rapid, flexible, all-in-one fastq demultiplexer,” (2021) [cited by applicant]
Yarnall et al., “Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases,” (2023) [cited by applicant]
Yu et al., “Highly Efficient Transgenesis in Ferrets Using CRISPR/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus,” (2019) Nature Scientific Reports, 9:1971. [cited by applicant]
Zhu, et al., “DICE, an efficient system for iterative genomic editing in human pluripotent stem cells”, Nucleic Acids Research, vol. 42, No. 5. e34. Dec. 4, 2013. [cited by applicant]